TY - JOUR AU - Leach, P. AU - Rutherford, S. A. AU - King, A. T. AU - Leggate, J. R. PY - 2004 DA - 2004// TI - Generic waiting lists for routine spinal surgery JO - J R Soc Med VL - 97 UR - https://doi.org/10.1177/014107680409700305 DO - 10.1177/014107680409700305 ID - Leach2004 ER - TY - JOUR AU - Noone, A. M. AU - Lund, J. L. AU - Mariotto, A. AU - Cronin, K. AU - McNeel, T. AU - Deapen, D. AU - Warren, J. L. PY - 2016 DA - 2016// TI - Comparison of SEER treatment data with Medicare claims JO - Med Care VL - 54 UR - https://doi.org/10.1097/MLR.0000000000000073 DO - 10.1097/MLR.0000000000000073 ID - Noone2016 ER - TY - JOUR AU - Jagsi, R. AU - Abrahamse, P. AU - Hawley, S. T. AU - Graff, J. J. AU - Hamilton, A. S. AU - Katz, S. J. PY - 2012 DA - 2012// TI - Underascertainment of radiotherapy receipt in surveillance, epidemiology, and end results registry data JO - Cancer VL - 118 UR - https://doi.org/10.1002/cncr.26295 DO - 10.1002/cncr.26295 ID - Jagsi2012 ER - TY - JOUR AU - Schrag, D. AU - Rifas-Shiman, S. AU - Saltz, L. AU - Bach, P. B. AU - Begg, C. B. PY - 2002 DA - 2002// TI - Adjuvant chemotherapy use for Medicare beneficiaries with stage II colon cancer JO - J Clin Oncol VL - 20 UR - https://doi.org/10.1200/JCO.2002.11.084 DO - 10.1200/JCO.2002.11.084 ID - Schrag2002 ER - TY - JOUR AU - Sanoff, H. K. AU - Carpenter, W. R. AU - Freburger, J. AU - Li, L. AU - Chen, K. AU - Zullig, L. L. AU - Goldberg, R. M. AU - Schymura, M. J. AU - Schrag, D. PY - 2012 DA - 2012// TI - Comparison of adverse events during 5-fluorouracil versus 5-fluorouracil/oxaliplatin adjuvant chemotherapy for stage III colon cancer: a population-based analysis JO - Cancer VL - 118 UR - https://doi.org/10.1002/cncr.27422 DO - 10.1002/cncr.27422 ID - Sanoff2012 ER - TY - JOUR AU - Sanoff, H. K. AU - Carpenter, W. R. AU - Martin, C. F. AU - Sargent, D. J. AU - Meyerhardt, J. A. AU - Sturmer, T. AU - Fine, J. P. AU - Weeks, J. AU - Niland, J. AU - Kahn, K. L. PY - 2012 DA - 2012// TI - Comparative effectiveness of oxaliplatin vs non-oxaliplatin-containing adjuvant chemotherapy for stage III colon cancer JO - J Natl Cancer Inst VL - 104 UR - https://doi.org/10.1093/jnci/djr524 DO - 10.1093/jnci/djr524 ID - Sanoff2012 ER - TY - STD TI - Meyerhardt JA, Li L, Sanoff HK, Carpenter Wt, Schrag D: Effectiveness of bevacizumab with first-line combination chemotherapy for Medicare patients with stage IV colorectal cancer. J Clin Oncol 2012, 30:608–615. ID - ref7 ER - TY - JOUR AU - Parikh, A. A. AU - Ni, S. AU - Koyama, T. AU - Pawlik, T. M. AU - Penson, D. PY - 2013 DA - 2013// TI - Trends in the multimodality treatment of resectable colorectal liver metastases: an underutilized strategy JO - J Gastrointest Surg VL - 17 UR - https://doi.org/10.1007/s11605-013-2325-z DO - 10.1007/s11605-013-2325-z ID - Parikh2013 ER - TY - JOUR AU - Lund, J. L. AU - Sturmer, T. AU - Sanoff, H. K. AU - Brookhart, A. AU - Sandler, R. S. AU - Warren, J. L. PY - 2013 DA - 2013// TI - Determinants of adjuvant oxaliplatin receipt among older stage II and III colorectal cancer patients JO - Cancer VL - 119 UR - https://doi.org/10.1002/cncr.27991 DO - 10.1002/cncr.27991 ID - Lund2013 ER - TY - STD TI - Shankaran V, Mummy D, Koepl L, Blough D, Yim YM, Yu E, Ramsey S. Adverse events associated with bevacizumab and chemotherapy in older patients with metastatic colorectal cancer. Clin Colorectal Cancer 2013, 12. 204-213:e201. ID - ref10 ER - TY - JOUR AU - Siegel, R. L. AU - Miller, K. D. AU - Jemal, A. PY - 2016 DA - 2016// TI - Cancer statistics, 2016 JO - CA Cancer J Clin VL - 66 UR - https://doi.org/10.3322/caac.21332 DO - 10.3322/caac.21332 ID - Siegel2016 ER - TY - JOUR AU - Moertel, C. G. AU - Fleming, T. R. AU - Macdonald, J. S. AU - Haller, D. G. AU - Laurie, J. A. AU - Goodman, P. J. AU - Ungerleider, J. S. AU - Emerson, W. A. AU - Tormey, D. C. AU - Glick, J. H. PY - 1990 DA - 1990// TI - Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma JO - N Engl J Med VL - 322 UR - https://doi.org/10.1056/NEJM199002083220602 DO - 10.1056/NEJM199002083220602 ID - Moertel1990 ER - TY - JOUR AU - Andre, T. AU - Colin, P. AU - Louvet, C. AU - Gamelin, E. AU - Bouche, O. AU - Achille, E. AU - Colbert, N. AU - Boaziz, C. AU - Piedbois, P. AU - Tubiana-Mathieu, N. PY - 2003 DA - 2003// TI - Semimonthly versus monthly regimen of fluorouracil and leucovorin administered for 24 or 36 weeks as adjuvant therapy in stage II and III colon cancer: results of a randomized trial JO - J Clin Oncol VL - 21 UR - https://doi.org/10.1200/JCO.2003.10.065 DO - 10.1200/JCO.2003.10.065 ID - Andre2003 ER - TY - JOUR AU - de Gramont, A. AU - Figer, A. AU - Seymour, M. AU - Homerin, M. AU - Hmissi, A. AU - Cassidy, J. AU - Boni, C. AU - Cortes-Funes, H. AU - Cervantes, A. AU - Freyer, G. PY - 2000 DA - 2000// TI - Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer JO - J Clin Oncol VL - 18 UR - https://doi.org/10.1200/JCO.2000.18.16.2938 DO - 10.1200/JCO.2000.18.16.2938 ID - de Gramont2000 ER - TY - STD TI - National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology. Accessed online March 15, 2018. http://www.nccn.org/professionals/physician_gls/pdf/colon.pdf UR - http://www.nccn.org/professionals/physician_gls/pdf/colon.pdf ID - ref15 ER - TY - JOUR AU - Morris, A. M. AU - Billingsley, K. G. AU - Hayanga, A. J. AU - Matthews, B. AU - Baldwin, L. M. AU - Birkmeyer, J. D. PY - 2008 DA - 2008// TI - Residual treatment disparities after oncology referral for rectal cancer JO - J Natl Cancer Inst VL - 100 UR - https://doi.org/10.1093/jnci/djn145 DO - 10.1093/jnci/djn145 ID - Morris2008 ER - TY - JOUR AU - Baldwin, L. M. AU - Dobie, S. A. AU - Billingsley, K. AU - Cai, Y. AU - Wright, G. E. AU - Dominitz, J. A. AU - Barlow, W. AU - Warren, J. L. AU - Taplin, S. H. PY - 2005 DA - 2005// TI - Explaining black-white differences in receipt of recommended colon cancer treatment JO - J Natl Cancer Inst VL - 97 UR - https://doi.org/10.1093/jnci/dji241 DO - 10.1093/jnci/dji241 ID - Baldwin2005 ER - TY - JOUR AU - Murphy, C. C. AU - Harlan, L. C. AU - Warren, J. L. AU - Geiger, A. M. PY - 2015 DA - 2015// TI - Race and insurance differences in the receipt of adjuvant chemotherapy among patients with stage III Colon Cancer JO - J Clin Oncol VL - 33 UR - https://doi.org/10.1200/JCO.2015.61.3026 DO - 10.1200/JCO.2015.61.3026 ID - Murphy2015 ER - TY - JOUR AU - Upadhyay, S. AU - Dahal, S. AU - Bhatt, V. R. AU - Khanal, N. AU - Silberstein, P. T. PY - 2015 DA - 2015// TI - Chemotherapy use in stage III colon cancer: a National Cancer Database analysis JO - Ther Adv Med Oncol VL - 7 UR - https://doi.org/10.1177/1758834015587867 DO - 10.1177/1758834015587867 ID - Upadhyay2015 ER - TY - JOUR AU - Veenstra, C. M. AU - Regenbogen, S. E. AU - Hawley, S. T. AU - Abrahamse, P. AU - Banerjee, M. AU - Morris, A. M. PY - 2015 DA - 2015// TI - Association of Paid Sick Leave with job Retention and Financial Burden among Working Patients with Colorectal Cancer JO - JAMA VL - 314 UR - https://doi.org/10.1001/jama.2015.12383 DO - 10.1001/jama.2015.12383 ID - Veenstra2015 ER - TY - JOUR AU - Berglund, A. AU - Cedermark, B. AU - Glimelius, B. PY - 2008 DA - 2008// TI - Is it deleterious to delay the start of adjuvant chemotherapy in colon cancer stage III? JO - Ann Oncol VL - 19 UR - https://doi.org/10.1093/annonc/mdm582 DO - 10.1093/annonc/mdm582 ID - Berglund2008 ER - TY - JOUR AU - Biagi, J. J. AU - Raphael, M. J. AU - Mackillop, W. J. AU - Kong, W. AU - King, W. D. AU - Booth, C. M. PY - 2011 DA - 2011// TI - Association between time to initiation of adjuvant chemotherapy and survival in colorectal cancer: a systematic review and meta-analysis JO - JAMA VL - 305 UR - https://doi.org/10.1001/jama.2011.749 DO - 10.1001/jama.2011.749 ID - Biagi2011 ER - TY - JOUR AU - Des Guetz, G. AU - Nicolas, P. AU - Perret, G. Y. AU - Morere, J. F. AU - Uzzan, B. PY - 2010 DA - 2010// TI - Does delaying adjuvant chemotherapy after curative surgery for colorectal cancer impair survival? A meta-analysis JO - Eur J Cancer VL - 46 UR - https://doi.org/10.1016/j.ejca.2010.01.020 DO - 10.1016/j.ejca.2010.01.020 ID - Des Guetz2010 ER - TY - JOUR AU - Massarweh, N. N. AU - Haynes, A. B. AU - Chiang, Y. J. AU - Chang, G. J. AU - You, Y. N. AU - Feig, B. W. AU - Cormier, J. N. PY - 2015 DA - 2015// TI - Adequacy of the National Quality Forum's Colon Cancer adjuvant chemotherapy quality metric: is 4 months soon enough? JO - Ann Surg VL - 262 UR - https://doi.org/10.1097/SLA.0000000000000859 DO - 10.1097/SLA.0000000000000859 ID - Massarweh2015 ER - TY - JOUR AU - Regenbogen, S. E. AU - Veenstra, C. M. AU - Hawley, S. T. AU - Banerjee, M. AU - Ward, K. C. AU - Kato, I. AU - Morris, A. M. PY - 2014 DA - 2014// TI - The personal financial burden of complications after colorectal cancer surgery JO - Cancer VL - 120 UR - https://doi.org/10.1002/cncr.28812 DO - 10.1002/cncr.28812 ID - Regenbogen2014 ER - TY - STD TI - Goodrich W. Dillman, don. Mail and telephone surveys-the Total design method. New York: John Wiley & Sons, 1978. J Advert. 1979;8:52–2. ID - ref26 ER - TY - JOUR AU - Phillips, K. A. AU - Milne, R. L. AU - Buys, S. AU - Friedlander, M. L. AU - Ward, J. H. AU - McCredie, M. R. AU - Giles, G. G. AU - Hopper, J. L. PY - 2005 DA - 2005// TI - Agreement between self-reported breast cancer treatment and medical records in a population-based breast Cancer family registry JO - J Clin Oncol VL - 23 UR - https://doi.org/10.1200/JCO.2005.03.002 DO - 10.1200/JCO.2005.03.002 ID - Phillips2005 ER - TY - JOUR AU - Schootman, M. AU - Jeffe, D. B. AU - West, M. M. AU - Aft, R. PY - 2005 DA - 2005// TI - Self-report by elderly breast cancer patients was an acceptable alternative to surveillance, epidemiology, and end results (SEER) abstract data JO - J Clin Epidemiol VL - 58 UR - https://doi.org/10.1016/j.jclinepi.2005.04.002 DO - 10.1016/j.jclinepi.2005.04.002 ID - Schootman2005 ER - TY - JOUR AU - Liu, Y. AU - Diamant, A. L. AU - Thind, A. AU - Maly, R. C. PY - 2010 DA - 2010// TI - Validity of self-reports of breast cancer treatment in low-income, medically underserved women with breast cancer JO - Breast Cancer Res Treat VL - 119 UR - https://doi.org/10.1007/s10549-009-0447-5 DO - 10.1007/s10549-009-0447-5 ID - Liu2010 ER - TY - BOOK AU - Rubin, D. B. PY - 1987 DA - 1987// TI - Multiple imputation for nonresponse in surveys PB - Wiley CY - New York UR - https://doi.org/10.1002/9780470316696 DO - 10.1002/9780470316696 ID - Rubin1987 ER - TY - STD TI - Kish L: Survey sampling. New York NY, John Wiley & Sons. 1965. ID - ref31 ER - TY - STD TI - Patwardhan MB, Samsa GP, McCrory DC, Fisher DA, Mantyh CR, Morse MA, Prosnitz RG, Cline KE, Gray RN. Cancer care quality measures: diagnosis and treatment of colorectal cancer. Evid Rep Technol Assess (Full Rep). 2006:1–116. ID - ref32 ER - TY - JOUR AU - Hopewood, I. PY - 2011 DA - 2011// TI - Analyzing quality of colorectal cancer care through registry statistics: a small community hospital example JO - J Registry Manag VL - 38 ID - Hopewood2011 ER - TY - JOUR AU - Bilimoria, K. Y. AU - Bentrem, D. J. AU - Stewart, A. K. AU - Winchester, D. P. AU - Ko, C. Y. PY - 2009 DA - 2009// TI - Comparison of commission on cancer-approved and -nonapproved hospitals in the United States: implications for studies that use the National Cancer Data Base JO - J Clin Oncol VL - 27 UR - https://doi.org/10.1200/JCO.2008.21.7018 DO - 10.1200/JCO.2008.21.7018 ID - Bilimoria2009 ER - TY - STD TI - American College of Surgeons: Rapid Quality Reporting System. https://www.facs.org/quality-programs/cancer/ncdb/qualitytools/rqrs. Accessed online May 19, 2017. UR - https://www.facs.org/quality-programs/cancer/ncdb/qualitytools/rqrs ID - ref35 ER - TY - JOUR AU - Stewart, A. K. AU - McNamara, E. AU - Gay, E. G. AU - Banasiak, J. AU - Winchester, D. P. PY - 2011 DA - 2011// TI - The rapid quality reporting system--a new quality of care tool for CoC-accredited cancer programs JO - J Registry Manag VL - 38 ID - Stewart2011 ER - TY - STD TI - Spain P, Teixeira-Poit S, Halpern MT, Castro K, Prabhu Das I, Adjei B, Lewis R, Clauser SB. The National Cancer Institute Community Cancer centers program (NCCCP): sustaining quality and reducing disparities in guideline-concordant breast and Colon Cancer care. Oncologist. 2017; ID - ref37 ER - TY - JOUR AU - Halpern, M. T. AU - Spain, P. AU - Holden, D. J. AU - Stewart, A. AU - McNamara, E. J. AU - Gay, G. AU - Das, I. P. AU - Clauser, S. PY - 2013 DA - 2013// TI - Improving quality of cancer care at community hospitals: impact of the National Cancer Institute Community Cancer centers program pilot JO - J Oncol Pract VL - 9 UR - https://doi.org/10.1200/JOP.2013.000937 DO - 10.1200/JOP.2013.000937 ID - Halpern2013 ER - TY - JOUR AU - Twelves, C. AU - Wong, A. AU - Nowacki, M. P. AU - Abt, M. AU - Burris, H. AU - Carrato, A. AU - Cassidy, J. AU - Cervantes, A. AU - Fagerberg, J. AU - Georgoulias, V. PY - 2005 DA - 2005// TI - Capecitabine as adjuvant treatment for stage III colon cancer JO - N Engl J Med VL - 352 UR - https://doi.org/10.1056/NEJMoa043116 DO - 10.1056/NEJMoa043116 ID - Twelves2005 ER - TY - JOUR AU - Haller, D. G. AU - Tabernero, J. AU - Maroun, J. AU - de Braud, F. AU - Price, T. AU - Van Cutsem, E. AU - Hill, M. AU - Gilberg, F. AU - Rittweger, K. AU - Schmoll, H. J. PY - 2011 DA - 2011// TI - Capecitabine plus oxaliplatin compared with fluorouracil and folinic acid as adjuvant therapy for stage III colon cancer JO - J Clin Oncol VL - 29 UR - https://doi.org/10.1200/JCO.2010.33.6297 DO - 10.1200/JCO.2010.33.6297 ID - Haller2011 ER - TY - JOUR AU - Lund, J. L. AU - Sturmer, T. AU - Harlan, L. C. AU - Sanoff, H. K. AU - Sandler, R. S. AU - Brookhart, M. A. AU - Warren, J. L. PY - 2013 DA - 2013// TI - Identifying specific chemotherapeutic agents in Medicare data: a validation study JO - Med Care VL - 51 UR - https://doi.org/10.1097/MLR.0b013e31823ab60f DO - 10.1097/MLR.0b013e31823ab60f ID - Lund2013 ER - TY - JOUR AU - Catalano, P. J. AU - Ayanian, J. Z. AU - Weeks, J. C. AU - Kahn, K. L. AU - Landrum, M. B. AU - Zaslavsky, A. M. AU - Lee, J. AU - Pendergast, J. AU - Harrington, D. P. PY - 2013 DA - 2013// TI - Cancer care outcomes research surveillance C: representativeness of participants in the cancer care outcomes research and surveillance consortium relative to the surveillance, epidemiology, and end results program JO - Med Care VL - 51 UR - https://doi.org/10.1097/MLR.0b013e318222a711 DO - 10.1097/MLR.0b013e318222a711 ID - Catalano2013 ER -